Rejuvenation Research: Difference between revisions
Content deleted Content added
Mr. Thoreau (talk | contribs) Furthermore, the descriptor "editorial board member" was added a few days ago without any prior discussion. Given that this significantly changes the reading of the article, this needs to be discussed prior to including. |
the inclusion of "editorial board member" has been discussed on the talk page; expanding the quote to make it more correct seems a no-brainer; change=ing to "have been" |
||
| Line 30: | Line 30: | ||
The [[editor-in-chief]] is [[Aubrey de Grey]]. The journal addresses such issues as [[circulatory system|cardiovascular]] aging, [[Biological immortality|cell immortalization]] and [[senescence]], [[cloning]]/[[Embryonic stem cell]]s, [[DNA repair|DNA damage/repair]], [[growth factor]]s, [[immunology]], [[invertebrate]] [[Maximum life span|lifespan]], [[neurodegeneration]], [[tissue engineering]], [[public policy]], [[gene]] targeting, [[gene therapy]], and [[genomics]]. |
The [[editor-in-chief]] is [[Aubrey de Grey]]. The journal addresses such issues as [[circulatory system|cardiovascular]] aging, [[Biological immortality|cell immortalization]] and [[senescence]], [[cloning]]/[[Embryonic stem cell]]s, [[DNA repair|DNA damage/repair]], [[growth factor]]s, [[immunology]], [[invertebrate]] [[Maximum life span|lifespan]], [[neurodegeneration]], [[tissue engineering]], [[public policy]], [[gene]] targeting, [[gene therapy]], and [[genomics]]. |
||
Appreciations of the journal have been rather divergent, with [[Michael R. Rose]] calling it "a heroic effort to jump-start research on postponing or slowing human aging",<ref>Michael Robertson Rose (2005). The long tomorrow: how advances in evolutionary biology can help us postpone aging. Page 148. Oxford University Press. ISBN 0-19-517939-0.</ref> whereas others judge it as being "somewhat fringy"<ref>Joseph Hooper (2005) The prophet of immortality. ''Popular Science'' '''266'''(1): 72.</ref> or "at the fringe of gerontology."<ref>{{cite journal |doi=10.1016/j.jaging.2008.05.004 |title=Medicalizing the optimal: Anti-aging medicine and the quandary of intervention |year=2008 |last1=Mykytyn |first1=Courtney E. |journal=Journal of Aging Studies |volume=22 |issue=4 |pages=313}}</ref> |
Appreciations of the journal have been rather divergent, with [[editorial board]] member [[Michael R. Rose]] calling it "a heroic effort to jump-start research on postponing or slowing human aging",<ref>Michael Robertson Rose (2005). The long tomorrow: how advances in evolutionary biology can help us postpone aging. Page 148. Oxford University Press. ISBN 0-19-517939-0.</ref> whereas others judge it as being "somewhat fringy"<ref>Joseph Hooper (2005) The prophet of immortality. ''Popular Science'' '''266'''(1): 72.</ref> or "situated admittedly at the fringe of gerontology by taking a controversial stance while demanding to be taken as serious science."<ref>{{cite journal |doi=10.1016/j.jaging.2008.05.004 |title=Medicalizing the optimal: Anti-aging medicine and the quandary of intervention |year=2008 |last1=Mykytyn |first1=Courtney E. |journal=Journal of Aging Studies |volume=22 |issue=4 |pages=313}}</ref> |
||
== Abstracting and indexing == |
== Abstracting and indexing == |
||
Revision as of 17:07, 12 November 2012
| Discipline | Antiaging |
|---|---|
| Language | English |
| Edited by | Aubrey de Grey |
| Publication details | |
Former name(s) | Journal of Anti-Aging Medicine |
| History | 1998–present |
| Publisher | Mary Ann Liebert (United States) |
| Frequency | Bimonthly |
| 3.826 (2011) | |
| ISO 4 | Find out here |
| Indexing | |
| ISSN | 1549-1684 (print) 1557-8577 (web) |
| LCCN | 2004214717 |
| OCLC no. | 54674277 |
| Links | |
Rejuvenation Research is a peer-reviewed bimonthly scientific journal published by Mary Ann Liebert that investigates rejuvenation.
The editor-in-chief is Aubrey de Grey. The journal addresses such issues as cardiovascular aging, cell immortalization and senescence, cloning/Embryonic stem cells, DNA damage/repair, growth factors, immunology, invertebrate lifespan, neurodegeneration, tissue engineering, public policy, gene targeting, gene therapy, and genomics.
Appreciations of the journal have been rather divergent, with editorial board member Michael R. Rose calling it "a heroic effort to jump-start research on postponing or slowing human aging",[1] whereas others judge it as being "somewhat fringy"[2] or "situated admittedly at the fringe of gerontology by taking a controversial stance while demanding to be taken as serious science."[3]
Abstracting and indexing
Rejuvenation Research is abstracted and indexed in:
- MEDLINE
- Current Contents/Clinical Medicine
- Science Citation Index Expanded
- EMBASE/Excerpta Medica
- Scopus
- CAB Abstracts
According to the Journal Citation Reports, the journal has a 2011 impact factor of 3.826.[4] This impact factor is partly due to 43% self citations without which it would have been 2.146.[4]
See also
References
- ^ Michael Robertson Rose (2005). The long tomorrow: how advances in evolutionary biology can help us postpone aging. Page 148. Oxford University Press. ISBN 0-19-517939-0.
- ^ Joseph Hooper (2005) The prophet of immortality. Popular Science 266(1): 72.
- ^ Mykytyn, Courtney E. (2008). "Medicalizing the optimal: Anti-aging medicine and the quandary of intervention". Journal of Aging Studies. 22 (4): 313. doi:10.1016/j.jaging.2008.05.004.
- ^ a b "Rejuvenation Research". 2011 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2012.
{{cite book}}:|access-date=requires|url=(help)CS1 maint: postscript (link)